Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid versus placebo to reduce severity of gestational diabetes mellitus
2019-002622-79Phase 3Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gestational diabetes mellitus (GDM) comparing Ursodeoxycholic acid with Placebo (2 arms). Primary endpoint: Maternal fasting glucose concentration. Started Feb 2020; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2019-002622-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002622-79.